Financial Performance - GAAP net income attributable to the company for Q3 2025 was $106.7 million, a significant increase from $2.4 million in Q3 2024, representing a growth of 4,367%[125] - Non-GAAP net income for Q3 2025 was $107.3 million, compared to $12.4 million in Q3 2024, reflecting a year-over-year increase of 765%[125] - The total net income before taxes for the company in the first nine months of 2025 was $480 million, compared to $150.1 million in the same period of 2024, indicating a growth of 219%[132] - Nelnet Bank reported a net income of $6.1 million in Q3 2025, recovering from a loss of $4.8 million in Q3 2024[132] - The company’s venture capital investments generated a net income of $33.5 million in Q3 2025, compared to $2.1 million in Q3 2024, marking a substantial increase[132] - Net income attributable to Nelnet, Inc. was $106.684 million for Q3 2025, compared to $2.388 million in Q3 2024, reflecting a significant increase[145] - Net income for Q3 2025 was $35,165 million, compared to a net loss of $3,457 million in Q3 2024, reflecting improved operational performance[151] - The before tax operating margin improved to 30.0% in Q3 2025 from (4.0)% in Q3 2024, indicating enhanced profitability[151] - For the nine months ended September 30, 2025, net income was $30.544 million, an increase from $33.409 million in the same period of 2024, reflecting a decrease of 2.6%[183] - For the nine months ended September 30, 2025, the net income was $125.76 million, compared to a net loss of $25.21 million for the same period in 2024[187] Revenue and Income Sources - The company recognized $32.9 million in non-recurring revenue in Q3 2025 from a contract modification with the Department of Education[136] - The company’s total revenue from its NDS segment was $46.3 million in Q3 2025, compared to a loss of $4.5 million in Q3 2024, indicating a strong recovery[132] - Total interest income for Q3 2025 was $205.96 million, a decrease from $240.48 million in Q3 2024, primarily due to a decrease in the average balance of loans[144] - LSS revenue for Q3 2025 was $151.05 million, up from $108.18 million in Q3 2024, indicating strong performance in the loan servicing segment[144] - Government loan servicing revenue reached $112,798 million in Q3 2025, up from $85,215 million in Q3 2024, attributed to increased loan servicing volume[152] - Private education and consumer loan servicing revenue rose to $24,293 million in Q3 2025, compared to $13,057 million in Q3 2024, reflecting growth in the loan portfolio[152] - Revenue from tuition payment plan services increased to $32.971 million in Q3 2025, up 4.1% from $31.659 million in Q3 2024[156] - Education technology services and payments revenue increased to $129.321 million in Q3 2025, up 9.6% from $118.179 million in Q3 2024[156] Expenses and Cost Management - Total operating expenses decreased to $225.736 million in Q3 2025 from $221.299 million in Q3 2024, primarily due to staff reductions in the LSS operating segment[145] - The company incurred total expenses of $294.872 million in Q3 2025, down from $322.635 million in Q3 2024[145] - Total operating expenses decreased to $108,710 million in Q3 2025 from $119,540 million in Q3 2024, due to cost-saving measures[150] - Salaries and benefits expenses decreased to $70,126 million in Q3 2025 from $76,820 million in Q3 2024, following staff reductions[150] - The company experienced an increase in salaries and benefits expenses, totaling $26.193 million for the three months ended September 30, 2025, compared to $23.852 million in 2024, reflecting an increase of 9.8%[186] Investments and Acquisitions - The company received cash proceeds of $410.9 million from the partial redemption of its investment in ALLO, resulting in a pre-tax gain of $175 million[135] - The company announced the acquisition of Finastra's Canadian student loan servicing business for approximately $93 million, expected to close in Q1 2026[139] - The company plans to use its liquidity to pursue strategic acquisitions, including a Canadian student loan servicing business for approximately $93 million, expected to close in Q1 2026[193] - The company has funded a total of $306.1 million in solar tax equity investments, with an additional commitment of $86.7 million, bringing the total commitment to $202.6 million[228] Loan Performance and Management - The company’s net interest income from its federally insured student loans remains a significant portion of its revenue, contributing to overall financial stability[123] - In Q3 2025, the company sold $203.3 million of consumer loans, resulting in a reversal of allowance for loan losses of $28.9 million, which increased income[137] - The loan portfolio in the AGM operating segment was $8.8 billion as of September 30, 2025, primarily consisting of federally insured loans[157] - Loan acquisitions in Q3 2025 totaled $1.586 billion, with a significant portion from consumer financing receivables[158] - AGM's allowance for loan losses showed a negative provision of $7.4 million for the three months ended September 30, 2025, compared to a provision of $11.9 million in the same period of 2024[170] - The allowance for loan losses and net charge-offs as a percentage of average loans will be detailed in the consolidated financial statements[175] Tax and Regulatory Matters - The effective tax rate for the year-to-date was 24.50% for the nine months ended September 30, 2025, with an expected range of 23% to 25% for the year ending December 31, 2025[145] - The effective tax rate for the three months ended September 30, 2025, was 24.4%, slightly up from 24.0% in the same period of 2024[180] Liquidity and Capital Management - As of September 30, 2025, the company's total sources of liquidity amounted to $1.66 billion, including $202.43 million in net cash and cash equivalents[191] - The company has a $495.0 million unsecured line of credit, with no amount outstanding as of September 30, 2025, available for future use[234] - Nelnet Bank's deposits are diversified, including retail, commercial, and institutional deposits, enhancing its liquidity position[226] - The company repurchased $377.6 million of its own debt during the third quarter of 2025, contributing to changes in investment interest income[183] Challenges and Future Outlook - The company continues to recognize loss reserves related to legacy solar construction contracts, with costs expected to be incurred for completion[145] - The company continues to face challenges with legacy construction contracts, recognizing loss reserves for costs to complete remaining projects[188] - The enactment of the One Big Beautiful Bill is expected to create opportunities for the company to expand its private education loan originations and acquisitions[190] - The company expects to recognize approximately $180 million in pre-tax income from current investments between October 1, 2025, and June 30, 2031[229]

Financial Performance - Revenues for the three months ended September 30, 2025, were $151.2 million, a 16.5% increase from $129.7 million in the prior year quarter [100]. - Net income for the same period was $12.0 million, representing a 59.9% increase from $7.5 million in the prior year quarter [100]. - Income from operations rose to $13.7 million, with an operating margin of 9.1%, up from 7.0% in the prior year quarter, primarily due to growth in higher margin offshore regions [126]. - Adjusted net income increased to $13.1 million, with an adjusted net income margin of 8.7%, compared to 7.0% in the prior year quarter [134]. - EBITDA for the three months ended September 30, 2025, was $18.1 million, with an adjusted EBITDA margin of 12.9%, compared to 12.0% in the prior year quarter [139]. - The effective tax rate decreased to 10.9% for the three months ended September 30, 2025, down from 20.8% in the prior year quarter [129]. Revenue Breakdown - The Retail & E-commerce vertical saw revenue growth of $7.9 million, or 25.0%, while the HealthTech vertical grew by $3.6 million, or 19.5% [116]. - The Telecommunications vertical experienced a revenue decline of $4.5 million, or 22.5%, compared to the prior year quarter [116]. - The largest client accounted for 10% of total revenues, while the top three clients represented 26% of consolidated revenues, indicating strong client diversification [111]. Costs and Expenses - Payroll and related costs increased to $77.9 million, a 14.6% rise, but as a percentage of revenue, it decreased to 51.5% from 52.4% [119]. - SG&A expenses increased by $0.3 million, or 1.2%, to $26.5 million for the three months ended September 30, 2025, driven by higher payroll costs and stock-based compensation [124]. - Reseller commissions and lead expenses surged by 119.7% to $8.3 million, driven by increased utilization of third-party affiliates [120]. Cash Flow and Liquidity - Free cash flow for the three months ended September 30, 2025, was $8.0 million, up from $4.1 million in the prior year, with net cash provided by operating activities at $15.7 million [143]. - Net cash as of September 30, 2025, was $21.1 million, an increase from $13.7 million as of June 30, 2025 [145]. - Cash and cash equivalents totaled $22.7 million as of September 30, 2025, with additional unused credit facilities of $67.4 million [147]. - The company expects existing cash and cash generated from operations to meet liquidity requirements for at least the next twelve months [149]. - Net cash inflow from operating activities for the three months ended September 30, 2025, was $15.7 million, up from $7.8 million in the same period last year, driven by increased revenues and lower working capital usage [156]. Investments and Financing - The company incurred $7.6 million in investing activities during the three months ended September 30, 2025, compared to $3.6 million in the prior year, primarily for offshore expansions and IT equipment purchases [157]. - Financing activities resulted in an expenditure of $0.6 million for the three months ended September 30, 2025, including $2.8 million for share repurchases [158]. - The company has a share repurchase program allowing up to $15 million in shares to be repurchased through May 12, 2026, with 91,658 shares repurchased for $2.7 million during the three months ended September 30, 2025 [152]. Operational Strategy - The company is actively integrating AI into its solutions to enhance customer experience and operational efficiency [103]. - The company is expanding its capacity in offshore regions to meet growing demand and optimize costs [106]. - The company’s offshore and nearshore workstations accounted for approximately 97% of total workstations as of September 30, 2025, up from 95% in the prior year [108]. Risk Management - A 10% appreciation/depreciation in the Philippine Peso against the U.S. dollar would have impacted expenses by approximately $3.7 million or $3.0 million, respectively, for the three months ended September 30, 2025 [165]. - The company did not have any outstanding balances on the HSBC Credit Facilities as of September 30, 2025, indicating no immediate interest rate risk exposure [168]. - The company’s cash management policies are designed to mitigate risks related to global cash, although it cannot guarantee against potential losses [154].

Financial Performance - For the three and nine months ended September 30, 2025, the company incurred a net loss of $30.1 million and $96.6 million, respectively, compared to a net loss of $24.8 million and net income of $81.8 million for the same periods in 2024 [103]. - The company recorded a net loss of $30.1 million for the three months ended September 30, 2025, compared to a net loss of $24.8 million in 2024 [130]. - License revenue for the three and nine months ended September 30, 2025, was $0, compared to $2.5 million and $167.5 million for the same periods in 2024, primarily due to the absence of new license agreements [131]. - Total operating expenses for the three months ended September 30, 2025, were $32.965 million, an increase of $6.236 million from $26.729 million in 2024 [130]. - Income tax benefit (expense) was zero for the three and nine months ended September 30, 2025, compared to a benefit of $0.3 million and an expense of $1.4 million in 2024 [139]. Cash and Capital - As of September 30, 2025, the company had cash, cash equivalents, and marketable securities of $383.9 million, following an initial public offering that raised gross proceeds of $140.0 million in February 2025 and a private placement that raised $150.0 million in September 2025 [104]. - The company completed its initial public offering in February 2025, issuing 8,750,000 shares at $16.00 per share, resulting in net proceeds of approximately $127.8 million [141]. - In September 2025, the company raised approximately $141.3 million through a private placement, selling 4,000,002 shares at $16.25 each and Pre-Funded Warrants [142]. - The company anticipates needing additional capital to fund operations and develop therapeutic candidates, with ongoing expenses expected to increase [144]. - The company may seek to raise capital through various means, including equity or debt financings, but adequate funding may not be available on acceptable terms [145]. Research and Development - The company expects significant increases in research and development expenses due to planned clinical trials for MZE829 and MZE782, further development of the Compass platform, and potential IND applications [103]. - Research and development expenses increased to $25.2 million for the three months ended September 30, 2025, from $19.9 million in 2024, reflecting a $5.3 million increase driven by higher personnel-related costs and clinical trial expenses [132]. - Research and development expenses for the nine months ended September 30, 2025, were $80.9 million, up from $61.3 million in 2024, marking a $19.6 million increase [133]. - The company plans to initiate two Phase 2 proof-of-concept trials for MZE782 in 2026, focusing on plasma Phe reduction in phenylketonuria and proteinuria reduction in chronic kidney disease [111]. - MZE782 demonstrated a favorable plasma pharmacokinetics profile with a half-life of 11 hours and consistent absorption, supporting a once- or twice-daily dosing regimen for future trials [109]. Operating Losses and Deficits - As of September 30, 2025, the company had an accumulated deficit of $455.0 million and does not expect positive cash flows from operations in the foreseeable future [103]. - The company has not generated any revenue from product sales and does not expect to do so in the foreseeable future, relying on financing through equity offerings and collaborations [102]. - The company incurred significant operating losses since inception, with expectations of increasing losses due to ongoing research and development activities [103]. - The company retains approximately 48% equity in Broadwing Bio LLC, a spin-out company formed to develop therapeutic antibody therapies, but expects dilution from convertible notes issued by Broadwing [106]. Other Financial Information - Interest and other income, net was $2.9 million for the three months ended September 30, 2025, up from $1.8 million in 2024, reflecting higher cash and marketable securities balances [137]. - Net cash used in operating activities was $84.2 million for the nine months ended September 30, 2025, compared to net cash provided of $98.4 million for the same period in 2024 [153]. - Net cash used in investing activities was $67.6 million for the nine months ended September 30, 2025, primarily due to purchases of marketable securities [154]. - Net cash provided by financing activities was $271.7 million for the nine months ended September 30, 2025, significantly up from $22.6 million in the same period in 2024 [155]. - The company has obligations of $4.6 million under consortium agreements with the University of Helsinki and Queen Mary University through December 31, 2027 [149]. Lease Obligations - The company has an operating lease for its headquarters in South San Francisco, which terminates in November 2030, with an option to extend for an additional eight years [148].

Exhibit 99.1 PondelWilkinson Inc. 2945 Townsgate Road, Suite 200 Westlake Village, CA 91361 Investor Relations T (310) 279 5980 Strategic Public Relations W www.pondel.com CONTACTS: Mark Astrachan SVP, Investor Relations & Corporate Development (951) 739-6200 Roger S. Pondel / Judy Lin NEWS PondelWilkinson Inc. RELEASE (310) 279-5980 MONSTER BEVERAGE REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS 2025 Third Quarter Highlights Corona, CA – November 6, 2025 – Monster Beverage Corporation (NASDAQ: MNST) today re ...

Financial Performance - Net sales increased 3.0% to $1.227 billion, with a contribution of 5.9% from the Simple Mills acquisition[5] - Net income decreased 39.2% to $39.5 million, representing 3.2% of sales, a 230-basis point decrease[5] - Adjusted EBITDA decreased 11.4% to $118.1 million, representing 9.6% of net sales, a 160-basis point decrease[5] - The company expects net sales for the fiscal year to be in the range of $5.254 billion to $5.306 billion, representing 2.9% to 4.0% growth compared to the prior year[6] - Adjusted diluted EPS is projected to be approximately $1.02 to $1.08, with a contribution of ($0.08) to ($0.07) from the Simple Mills acquisition[6] - Branded Retail net sales increased 6.9% to $812.8 million, driven by the Simple Mills acquisition[9] - The company reported a net income of $39,534 for the 12-week period, down from $64,984 in the prior year, resulting in a diluted EPS of $0.19[24] - For the 12-week period ended October 4, 2025, net income per diluted common share was $0.19, compared to $0.31 for the same period in 2024, representing a decrease of 38.7%[32] - For the 40-week period ended October 4, 2025, net income per diluted common share was $0.71, down from $0.97 in the same period of 2024, a decrease of 26.8%[32] Cash Flow and Expenses - Cash flow from operating activities increased $38.5 million to $320.8 million year-to-date[8] - Selling, distribution, and administrative expenses were 38.8% of net sales, a 10-basis point increase[9] - Selling, distribution, and administrative expenses for the 12-week period ended October 4, 2025, were $475,952, compared to $460,359 in the same period of 2024, an increase of 3.9%[34] - The company incurred restructuring charges of $5,510 for the 12-week period, compared to no charges in the same period last year[24] - The company incurred acquisition and integration-related costs of $1,735 for the 12-week period ended October 4, 2025, compared to $0 in the same period of 2024[36] Sales and Market Performance - Net sales for the 12-week period ended October 4, 2025, were $1,226,554, representing a 3.0% increase from $1,190,561 in the same period last year[24] - Branded Retail sales increased by 6.9% to $812,760 for the 12-week period, while Other sales decreased by 3.8% to $413,794[28] - For the 40-week period ended October 4, 2025, total net sales were $4,023,619, a 0.8% increase from $3,992,362[28] - The company experienced a total percentage point change in net sales of 3.0% for Branded Retail and a decline of 3.8% for Other in the 12-week period[29] Adjusted Metrics - Adjusted EBITDA measures are used as the primary performance measure in the company's compensation plan, reflecting the importance of core operational insights[18] - Adjusted EBITDA for the 12-week period ended October 4, 2025, was $118,117, compared to $133,310 for the same period in 2024, indicating a decline of 11.4%[36] - The adjusted net income for the 12-week period ended October 4, 2025, was $48,677, down from $69,332 in the same period of 2024, a decrease of 29.8%[38] - The adjusted EBITDA margin for the 12-week period ended October 4, 2025, was 9.6%, compared to 11.2% for the same period in 2024, showing a decline of 1.6 percentage points[36] Debt and Cash Position - Long-term debt increased to $1,779,623 as of October 4, 2025, compared to $1,021,644 at the end of the previous year[21] - Cash and cash equivalents at the end of the period were $16,731, up from $5,005 at the end of the previous year[21] - Total depreciation and amortization for the 40-week period ended October 4, 2025, was $128,967, compared to $122,393 for the same period in 2024, an increase of 5.4%[36] Future Outlook - The company is narrowing its 2025 financial outlook to reflect greater certainty entering the fourth quarter[4] - The company expects adjusted net income per diluted common share for the full year fiscal 2025 to range from $1.02 to $1.08[38]

Financial Performance - Earnings from continuing operations were $(426) million ($(0.81) per diluted share) in Q3 2025, a decline from $111 million ($0.31 per diluted share) in Q3 2024 [169]. - Adjusted EBITDA from continuing operations was $859 million in Q3 2025, representing a 28% sequential increase [173]. - Net sales for Q3 2025 reached $6.22 billion, a 1% increase from Q2 2025 and a 56% increase from Q3 2024, driven primarily by higher sales prices [203]. - Diluted earnings per share from continuing operations for Q3 2025 was $(2.09), a decrease from $0.42 in Q2 2025 and $0.14 in Q3 2024 [201]. - An income tax benefit of $250 million was recorded for Q3 2025, resulting in an effective income tax rate of 37% [210]. - The Company reported cash provided by operations of $793 million for the first nine months of 2025, down from $1.3 billion in the same period of 2024, primarily due to significant payments impacting cash flow by approximately $670 million [225]. Business Divestitures and Impairments - The company recorded a $1.0 billion impairment related to the divestment of the Global Cellulose Fibers business, expected to close by year-end 2025 [173][178]. - The divestiture of the Global Cellulose Fibers business was agreed for $1.5 billion, with preferred stock consideration of $190 million [178]. - The Company announced a definitive agreement to sell its Global Cellulose Fibers business, with all related operating results classified as Discontinued Operations [215]. - Discontinued operations included net special items expense of $1.0 billion for Q3 2025, compared to $1 million and $15 million for Q3 2024 and Q2 2025, respectively [216]. Cost Management and Operational Efficiency - The company is focusing on cost management and operational efficiency, including outsourcing a portion of its North American IT services [182]. - The third quarter results reflect improved price realization and cost management, contributing to strategic wins across various customer segments [171][172]. - The company anticipates lower adjusted EBITDA from continuing operations in PS NA for Q4 2025 due to reduced volumes and increased maintenance costs [174]. Capital Expenditures and Cash Flow - Capital expenditures totaled $1.2 billion in the first nine months of 2025, compared to $661 million in the same period of 2024, with full-year 2025 capital expenditures expected to be approximately $1.8 billion to $1.9 billion [227]. - Free cash flow for the first nine months of 2025 was $(414) million, compared to $620 million for the same period in 2024 [198]. - Cash used for investment activities totaled $(478) million in the first nine months of 2025, an improvement from $(634) million in the same period of 2024 [226]. Debt and Financing - The Company maintained a long-term credit rating of BBB (stable outlook) and Baa2 (stable outlook) by S&P and Moody's, respectively, as of September 30, 2025 [229]. - The Company had no borrowings outstanding under its commercial paper program or USD denominated committed bank facility as of September 30, 2025 [228]. - The Company amended its £1.25 billion credit facility agreement to align with International Paper's existing credit facilities, allowing for additional flexibility for potential reorganization of subsidiaries [233]. - As of September 30, 2025, the Company had approximately $1.2 billion (€1.035 billion) borrowings outstanding under the credit facility, with no restrictive covenants other than compliance with negative covenants [233]. - The Company continues to rely on debt and capital markets for long-term funding not provided by operating cash flows, guided by capital structure planning objectives [237]. Shareholder Returns - Cash dividend payments totaled $733 million for the first nine months of 2025, compared to $482 million for the same period in 2024, maintaining dividends at $1.3875 per share [240]. - During the first nine months of 2025, the Company used 3.6 million shares of treasury stock for incentive plans and acquired 1.1 million shares related to restricted stock tax withholdings, totaling $64 million in payments [238]. - The Company has approximately $2.96 billion of shares of common stock remaining authorized for purchase under its share repurchase program as of September 30, 2025 [238]. Economic and Market Conditions - The company is navigating a complex macroeconomic landscape, with factors such as elevated interest rates and shifting consumer behavior impacting industrial production [183]. - The enactment of the One Big Beautiful Bill Act introduced tax policy changes, which the company is evaluating for potential implications on its financial statements [185].

Financial Performance - Total revenues for the three months ended September 30, 2025, were $311,455 thousand, slightly up from $309,588 thousand in the same period of 2024, reflecting a 0.6% increase[17]. - Net income for the three months ended September 30, 2025, was $163,497 thousand, down from $180,669 thousand in 2024, indicating a decrease of 9.5%[19]. - The company reported a total comprehensive income of $226,054 thousand for the three months ended September 30, 2025, compared to $314,990 thousand in 2024, a decrease of 28.2%[19]. - Basic net income per common share for the three months ended September 30, 2025, was $1.11, down from $1.16 in 2024, a decline of 4.3%[17]. - Net income for the nine months ended September 30, 2025, was $497,083, compared to $525,330 for the same period in 2024, reflecting a decrease of approximately 5.4%[24]. - The company reported comprehensive income of $662,753 for the nine months ended September 30, 2025, compared to $653,746 for the same period in 2024, showing a slight increase of about 1.6%[22]. Assets and Liabilities - Total assets increased to $6,876,443 thousand as of September 30, 2025, up from $6,521,531 thousand at December 31, 2024, representing a growth of 5.4%[15]. - Total liabilities increased to $1,559,157 thousand as of September 30, 2025, from $1,525,435 thousand at December 31, 2024, reflecting a growth of 2.2%[15]. - Total equity rose to $5,317,286 thousand as of September 30, 2025, compared to $4,996,096 thousand at December 31, 2024, an increase of 6.4%[15]. - Cash and cash equivalents at the end of the period on September 30, 2025, were $543,577, down from $673,363 at the end of September 2024, a decrease of about 19.2%[24]. Investment Income and Losses - Net investment income for the three months ended September 30, 2025, was $68,611 thousand, up from $61,056 thousand in 2024, representing an increase of 12.5%[17]. - Net investment income for the nine months ended September 30, 2025, was $197,532, an increase from $177,940 in 2024, indicating a growth of approximately 11%[41]. - For the three months ended September 30, 2025, net investment losses amounted to $2,834,000, compared to losses of $1,243,000 in the same period of 2024, reflecting a significant increase in losses[42]. - For the nine months ended September 30, 2025, net investment losses totaled $13,420,000, compared to $15,640,000 for the same period in 2024, indicating a decrease in losses year-over-year[42]. Insurance and Loss Reserves - Total loss reserves as of September 30, 2025, amounted to $572.1 million, an increase from $524.7 million as of December 31, 2024[105]. - For the nine months ended September 30, 2025, losses and LAE incurred related to insured events of the current accident year were $221 million, compared to $212 million for the same period in 2024[110]. - The gross loss reserves for domestic mortgage insurance increased to $566.9 million as of September 30, 2025, from $520.0 million at the end of 2024[105]. - The company recorded favorable reserve adjustments of $140 million primarily on prior accident year reserves due to improved cure performance of delinquencies[110]. Shareholder Activities - The company repurchased common stock totaling $255,377 during the nine months ended September 30, 2025, compared to $169,321 in the same period of 2024, reflecting an increase of approximately 50.9%[24]. - Cash dividends paid to Genworth were $25.1 million for the three months ended September 30, 2025, and $73.4 million for the nine months ended September 30, 2025[142]. - Total dividends declared and paid per common share for 2025 was $0.605, down from $0.715 in 2024[158]. - During Q3 2025, the company repurchased 2,824,499 shares at an average price of $37.23 per share, compared to 2,096,329 shares at $34.04 per share in Q3 2024[155]. Market Conditions and Performance Metrics - The U.S. mortgage origination market remained slow due to elevated mortgage rates, impacting housing affordability[166]. - The loss ratio for Q3 2025 was 15%, up from 5% in Q3 2024, with a reserve release of $45 million in Q3 2025 compared to $65 million in Q3 2024[172][192]. - The primary persistency rate remained stable at 83% for both Q3 2025 and Q3 2024, indicating strong retention of in-force policies[170]. - New insurance written (NIW) for Q3 2025 was $14.0 billion, representing a 3% increase compared to Q3 2024[170].

Financial Performance - Net sales for the three months ended September 30, 2025, were $1,140.4 million, a decrease of 2.0% compared to $1,163.8 million in the same period of 2024[111]. - For the six months ended September 30, 2025, net sales were $2,215.9 million, down 7.9% from $2,405.1 million in the same period of 2024[111]. - Mixed-signal microcontrollers accounted for 51.3% of net sales in Q3 2025, down from 51.1% in Q3 2024, with a decrease in sales of 1.7% year-over-year[116][117]. - Analog product line sales increased by 10.1% in Q3 2025, accounting for 28.2% of net sales, compared to 25.1% in Q3 2024[119][121]. - Other product line sales decreased by 15.4% in Q3 2025, representing 20.5% of net sales, down from 23.8% in Q3 2024[123][124]. - Total revenue for the six months ended September 30, 2025, was $789.9 million, with a gross profit of $261.5 million[182]. - The company reported a total net loss of $132.0 million for the six months ended September 30, 2025[182]. Profitability Metrics - Gross profit margin for the three months ended September 30, 2025, was 55.9%, down from 57.4% in the same period of 2024[109]. - Operating income for the three months ended September 30, 2025, was 7.8%, a decline from 12.6% in the same period of 2024[109]. - Gross profit for Q3 2025 was $637.9 million, or 55.9% of net sales, compared to $668.5 million, or 57.4% of net sales in Q3 2024, indicating a decline in gross margin[130]. - The company anticipates fluctuations in gross margins driven by capacity utilization, product mix, and economic conditions[137]. Research and Development - Research and development expenses as a percentage of net sales increased to 23.0% for the three months ended September 30, 2025, compared to 20.7% in the same period of 2024[109]. - R&D expenses for Q3 2025 were $262.3 million, or 23.0% of net sales, up from $240.7 million, or 20.7% in Q3 2024[138]. - R&D expenses for the first half of 2025 increased to $517.8 million, or 23.4% of net sales, compared to $482.4 million, or 20.1% in the same period of 2024[138]. - The company plans to continue investments in new and enhanced products, focusing on mixed-signal microcontrollers, digital signal controllers, and FPGAs[105]. Operational Changes - The closure of the Tempe, Arizona wafer fabrication facility (Fab 2) was completed in May 2025, with production being transferred to Oregon and Colorado locations[102]. - The company aims to maintain a high level of manufacturing control by owning wafer fabrication facilities, which contributes to being one of the lowest cost producers in the embedded control industry[102]. - The company plans to continue investing in internal assembly and test capabilities to enhance cost savings and control over manufacturing processes[135]. Cash Flow and Financing - Net cash provided by operating activities for the first half of 2025 was $363.7 million, down from $420.7 million in the same period of 2024[165]. - Net cash used in investing activities was $98.9 million in the first half of 2025, compared to $189.7 million in the same period of 2024[166]. - Cash and cash equivalents at September 30, 2025 were $236.8 million, a decrease of $534.9 million from March 31, 2025[163]. - Net cash used in financing activities was $799.7 million for the six months ended September 30, 2025, compared to $264.6 million in the same period of 2024[168]. - Cash dividends paid to common stockholders in the first six months of fiscal 2026 totaled $491.3 million, compared to $486.3 million in the same period of fiscal 2025[169]. - The company established a Commercial Paper program with a maximum principal amount of $2.75 billion, with $1.12 billion outstanding as of September 30, 2025[172]. Debt and Assets - As of September 30, 2025, total assets were $9,250.7 million, while total liabilities were $14,586.0 million[182]. - As of September 30, 2025, the company's total current and long-term debt amounted to $5.41 billion, all of which is fixed rate[183]. - The company plans to finance the repayment of fixed rate debt maturing within the next 12 months using available borrowings under its Revolving Credit Facility or Commercial Paper program[183]. - Changes in interest rates will significantly impact the company's interest expense if it refinances fixed rate debt with variable rate debt[183]. - The company has approximately $1.56 billion remaining for stock repurchases under its authorized program as of September 30, 2025[174]. Market and Economic Conditions - Foreign customers represented approximately 75% of total net sales in Q3 2025, up from 74% in Q3 2024[129]. - Distributors accounted for approximately 45% of net sales in Q3 2025, with Arrow Electronics being the largest distributor, contributing 11% of net sales[125]. - Inflation has not materially affected the company's operating results in recent periods[184]. - The company may struggle to offset higher costs due to inflation through price increases, which could adversely impact operating results[184].

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission File Number: 0-21184 MICROCHIP TECHNOLOGY INCORPORATED (Exact Name of Registrant as Specified in Its Charter) (State o ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-40815 Definitive Healthcare Corp. (Exact name of registrant as specified in its charter) Delaware 86-3988281 (State or other ...